Correlation Between Nextage Therapeutics and Kamada

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nextage Therapeutics and Kamada at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nextage Therapeutics and Kamada into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nextage Therapeutics and Kamada, you can compare the effects of market volatilities on Nextage Therapeutics and Kamada and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nextage Therapeutics with a short position of Kamada. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nextage Therapeutics and Kamada.

Diversification Opportunities for Nextage Therapeutics and Kamada

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nextage and Kamada is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Nextage Therapeutics and Kamada in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kamada and Nextage Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nextage Therapeutics are associated (or correlated) with Kamada. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kamada has no effect on the direction of Nextage Therapeutics i.e., Nextage Therapeutics and Kamada go up and down completely randomly.

Pair Corralation between Nextage Therapeutics and Kamada

Assuming the 90 days trading horizon Nextage Therapeutics is expected to generate 2.81 times more return on investment than Kamada. However, Nextage Therapeutics is 2.81 times more volatile than Kamada. It trades about 0.05 of its potential returns per unit of risk. Kamada is currently generating about 0.07 per unit of risk. If you would invest  6,830  in Nextage Therapeutics on September 14, 2024 and sell it today you would earn a total of  500.00  from holding Nextage Therapeutics or generate 7.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy97.87%
ValuesDaily Returns

Nextage Therapeutics  vs.  Kamada

 Performance 
       Timeline  
Nextage Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Kamada 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kamada may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Nextage Therapeutics and Kamada Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nextage Therapeutics and Kamada

The main advantage of trading using opposite Nextage Therapeutics and Kamada positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nextage Therapeutics position performs unexpectedly, Kamada can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kamada will offset losses from the drop in Kamada's long position.
The idea behind Nextage Therapeutics and Kamada pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital